-
70210-10Highly selective COX-2 inhibitor (IC<sub>50</sub> 50 >500 µM (COX-1).
-
70210-5Highly selective COX-2 inhibitor (IC<sub>50</sub> 50 >500 µM (COX-1).
-
70210-50Highly selective COX-2 inhibitor (IC<sub>50</sub> 50 >500 µM (COX-1).
-
72510-1A trifluoromethyl analog of an isatin sulfonamide compound that selectively inhibits caspases-3 and -7.
-
72510-10A trifluoromethyl analog of an isatin sulfonamide compound that selectively inhibits caspases-3 and -7.
-
72510-100A trifluoromethyl analog of an isatin sulfonamide compound that selectively inhibits caspases-3 and -7.
-
72510-5A trifluoromethyl analog of an isatin sulfonamide compound that selectively inhibits caspases-3 and -7.
-
13747-1A butaprost analog with a 5,6-double bond and without the methyl ester.
-
13747-10A butaprost analog with a 5,6-double bond and without the methyl ester.
-
13747-5A butaprost analog with a 5,6-double bond and without the methyl ester.
-
18590-1CAY10410 is an analog of PGD2/PGJ2 with structural modifications intended to give it PPAR&gamma ligand activity and resistance to metabolism. 15-deoxy-.
-
18590-10CAY10410 is an analog of PGD2/PGJ2 with structural modifications intended to give it PPAR&gamma ligand activity and resistance to metabolism. 15-deoxy-.